marco m elser executive profile  biography  bloomberg july    am et electronic equipment instruments and components company overview of translux corporation snapshotpeople  overviewboard memberscommittees executive profile marco m elser director translux corporationagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr marco m elser serves as the managing director of elser  co mr elser serves as a managing director of warburg pincus llc he served as chief executive officer and partner of capital markets at advicorp plc until january   from  to  he served as a first vice president of merrill lynch capital markets in rome and london he was cofounder of protalex inc from  to  he served as international vice president of northeast securities and was  responsible for the italian office which he founded in  mr elsers extensive knowledge of international finance and commerce allows him to make valuable contributions he serves as the chairman of universal voltronics corp mr elser served as the chairman of the board at pine brook capital from  to  he has been a director of translux corporation since may   mr elser has been a director of north hills signal processing corpformerly porta systems corp since  and protalex inc since february  he has been a member of advisory board at onemedplace since april  he served as director at pine brook capital from  to  mr elser is also president of the harvard club of italy he received his ba in economics from harvard college in read full background corporate headquarters  park avenuenew york new york united statesphone fax  board members memberships chairmanuniversal voltronics corppresentdirectornorth hills signal processing corppresentdirectortranslux corporationpresentdirectorprotalex inc education ba harvard college other affiliations north hills signal processing corpuniversal voltronics corpprotalex incadvicorp plcharvard collegeonemedplace annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation total annual cash compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationnamepositioncompanycompensationjengwu tai president ceo  directorsharp corporationshuanglang peng chairman and chief executive officer au optronics corpminoru usui president and representative directorseiko epson corporationsangbeom han chairman of the board  ceolg display co ltdbjordan wu founder chief executive officer president and directorhimax technologies inccompensation as of fiscal year  sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact translux corporation please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close protalex announces appointment of marco m elser to its board of directors  business wire protalex announces appointment of marco m elser to its board of directors february    am eastern standard time florham park njbusiness wireprotalex inc otcqbprtx a clinicalstage biopharmaceutical company today announced that marco m elser has been appointed to its board of directors mr elser is a partner with advicorp plc a londonbased investment banking firm mr elser’s appointment fills the vacancy on the board resulting from the untimely passing of john doherty last month mr doherty was a cofounder of protalex and served as a director and a member of its scientific advisory board since november  from  to  mr elser served as international vice president of northeast securities managing distressed funds for family offices and small institutions prior to that from  through  he served as a first vice president of merrill lynch capital markets in rome and london mr elser served on the board of directors of pine brook capital a shelton ctbased engineering company from  to  and was its chairman from  through  he is presently a director since  of north hills signal processing corporation a long island nybased technology company and a director since  of translux corporation a norwalk ctbased designer and manufacturer of digital signage display solutions mr elser is also the president of the harvard club of italy an association he founded in  with other alumni in italy where he has been living since  he received his ba in economics from harvard college in  commenting on mr elser’s appointment arnold kling president of protalex noted “we expect that marco’s extensive knowledge of international finance and commerce will allow him to make valuable contributions to the board as we enter an exciting growth period for protalex we are deeply appreciative of his willingness to join the board and assist us in advancing the development and commercialization of our lead drug prtx” james w dowe iii vice chairman of the protalex scientific advisory board commented on the loss of the company’s founder “john’s unfettered dedication passion and commitment to finding a more effective and cost efficient clinical treatment for rheumatoid arthritis has been a driving force in protalex’s history and in the various initiatives to date he will be deeply missed by me and my colleagues at protalex he was one of a kind” about protalex inc protalex inc is a clinicalstage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis ra protalex’s lead product prtx is a formulation of a proprietary highly purified form of staphylococcal protein a which is an immunomodulatory protein produced by bacteria protalex has completed a phase b clinical trial in adult patients with active ra in south africa which demonstrated that prtx was generally safe and well tolerated at all dose levels and at the higher doses more patients showed improvement in their cdai clinical disease activity index for ra than did patients at the lower dose or placebo cohorts prtx has the ability at very low concentrations to bind to human blymphocytes and macrophages and to activate processes that mediate inflammation in certain autoimmune diseases laboratory studies indicate that the mechanism involves interaction with specific immunologic signaling pathways the safety tolerability and pharmacokinetics of prtx have now been characterized in four clinical studies with a fifth us study nearing completion forwardlooking statements statements in this press release that are not statements of historical or current fact constitute forwardlooking statements such forwardlooking statements involve known and unknown risks uncertainties and other unknown factors that could cause the companys actual operating results to be materially different from any historical results or from any future results expressed or implied by such forwardlooking statements in addition to statements that explicitly describe these risks and uncertainties readers are urged to consider statements that contain terms such as believes belief expects expect intends intend anticipate anticipates plans plan to be uncertain and forwardlooking the forwardlooking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the companys filings with securities and exchange commission contacts lhaanne marie fields afieldslhaicom contacts lhaanne marie fields afieldslhaicom search advanced news search advanced news search log in sign up protalex announces appointment of marco m elser to its board of directors  protalex inc prtx protalex inc on linkedin protalex inc on facebook protalex inc on twitter protalex inc on google plus home news press releases protalex announces appointment of marco m navigation protalex announces appointment of marco m elser to its board of directors florham park nj protalex inc otcqbprtx a clinicalstage biopharmaceutical company today announced that marco m elser has been appointed to its board of directors mr elser is a partner with advicorp plc a londonbased investment banking firm mr elser’s appointment fills the vacancy on the board resulting from the untimely passing of john doherty last month mr doherty was a cofounder of protalex and served as a director and a member of its scientific advisory board since november  from  to  mr elser served as international vice president of northeast securities managing distressed funds for family offices and small institutions prior to that from  through  he served as a first vice president of merrill lynch capital markets in rome and london mr elser served on the board of directors of pine brook capital a shelton ctbased engineering company from  to  and was its chairman from  through  he is presently a director since  of north hills signal processing corporation a long island nybased technology company and a director since  of translux corporation a norwalk ctbased designer and manufacturer of digital signage display solutions mr elser is also the president of the harvard club of italy an association he founded in  with other alumni in italy where he has been living since  he received his ba in economics from harvard college in  commenting on mr elser’s appointment arnold kling president of protalex noted “we expect that marco’s extensive knowledge of international finance and commerce will allow him to make valuable contributions to the board as we enter an exciting growth period for protalex we are deeply appreciative of his willingness to join the board and assist us in advancing the development and commercialization of our lead drug prtx” james w dowe iii vice chairman of the protalex scientific advisory board commented on the loss of the company’s founder “john’s unfettered dedication passion and commitment to finding a more effective and cost efficient clinical treatment for rheumatoid arthritis has been a driving force in protalex’s history and in the various initiatives to date he will be deeply missed by me and my colleagues at protalex he was one of a kind” about protalex inc protalex inc is a clinicalstage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis ra protalex’s lead product prtx is a formulation of a proprietary highly purified form of staphylococcal protein a which is an immunomodulatory protein produced by bacteria protalex has completed a phase b clinical trial in adult patients with active ra in south africa which demonstrated that prtx was generally safe and well tolerated at all dose levels and at the higher doses more patients showed improvement in their cdai clinical disease activity index for ra than did patients at the lower dose or placebo cohorts prtx has the ability at very low concentrations to bind to human blymphocytes and macrophages and to activate processes that mediate inflammation in certain autoimmune diseases laboratory studies indicate that the mechanism involves interaction with specific immunologic signaling pathways the safety tolerability and pharmacokinetics of prtx have now been characterized in four clinical studies with a fifth us study nearing completion forwardlooking statements statements in this press release that are not statements of historical or current fact constitute forwardlooking statements such forwardlooking statements involve known and unknown risks uncertainties and other unknown factors that could cause the companys actual operating results to be materially different from any historical results or from any future results expressed or implied by such forwardlooking statements in addition to statements that explicitly describe these risks and uncertainties readers are urged to consider statements that contain terms such as believes belief expects expect intends intend anticipate anticipates plans plan to be uncertain and forwardlooking the forwardlooking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the companys filings with securities and exchange commission lhaanne marie fields afieldslhaicom source protalex inc released february   sign up for email alerts be the first to receive breaking news sign up  facebook facebook   ？ facebook ？？：？，。english us한국어français francebahasa indonesiapolskiespañolportuguês brasildeutschitalianomessengerfacebook liteinstagramcookie facebook   board of directors  protalex inc prtx protalex inc on linkedin protalex inc on facebook protalex inc on twitter protalex inc on google plus home about navigation board of directors arnold p kling president and director arnold p kling mr kling has served as our president and director since november  for the past  years mr kling has been the senior managing partner for a group of private equity investment funds that invest and manage early stage companies whose technologies have the potential to disrupt their targeted markets from  to  he was a senior executive and general counsel of a nasdaq listed licensing and multimedia company from  through  mr kling was an associate and partner in the corporate and financial services department of tannenbaum helpern syracuse  hirschtritt llp a midsize new york law firm mr kling received a bachelor of science degree from new york university in international business in  and a juris doctor degree from benjamin cardozo school of law in  kirk m warshaw chief financial officer secretary and director kirk m warshaw mr warshaw has served as our chief financial officer secretary and director since november  mr warshaw is a financial professional who since  has provided clients in various industries with advice on accounting corporate finance and general business matters prior to starting his own consulting firm from  to  he held the various titles of controller chief financial officer president and chief executive officer at three separate financial institutions in new jersey from  through  mr warshaw was a senior accountant at the public accounting firm of deloitte haskins  sells mr warshaw is a  graduate of lehigh university and has been a cpa in new jersey since  marco m elser director marco m elser has served as a director since february  for over five years mr elser has been a partner with advicorp plc a londonbased investment banking firm from  to  mr elser served as international vice president of northeast securities managing distressed funds for family offices and small institutions prior to that from  through  he served as a first vice president of merrill lynch capital markets in rome and london mr elser served on the board of directors of pine brook capital a shelton ctbased engineering company from  to  and was its chairman from  through  he is presently a director since  of north hills signal processing corporation a technology company and a director since  of translux corporation a designer and manufacturer of digital signage display solutions from  to  mr elser was also the president of the harvard club of italy an association he founded with other alumni in italy where he has been living since  he received his ba in economics from harvard college in  mr elsers extensive knowledge of international finance and commerce allows him to make valuable contributions as one of our directors latest news jun   •  am edt protalex issues letter to shareholders about protalex protalex is a biotechnology company developing a new class of drugs with the potential to revolutionize the treatment of autoimmune diseases learn more autoimmune diseases today in the us millions of individuals suffer from autoimmune diseases with rheumatoid arthritis and immune thrombocytopenia representing both large and niche markets learn more sign up for email alerts be the first to receive breaking news sign up marco m elser  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in marco m elser board member at translux corporation view full profile are you marco m elser claim your profile   sign up for equilar atlas and view marco m elsers full profile with equilar atlas you can identify corporate executives in marco m elsers network and community follow changes in marco m elsers employment and moneyinmotion connect with marco m elser through your network of contacts marco m elsers executive work history current board member translux corporation past to view marco m elsers complete executive work history sign up now age      marco m elsers biography marco m elser has served as a director since february  for over five years mr elser has been a partner with advicorp plc a londonbased investment banking firm from  to  mr elser served as international vice president of northeast securities managing distressed funds for family offices and small institutions prior to that from  through  he served as a first vice president of merrill lynch capital markets in rome and london mr elser served on the board of directors of pine brook capital a shelton ctbased engineering company from  to  and was its chairman from  through  he is presently a d  read more marco m elser has served as a director since february  for over five years mr elser has been a partner with advicorp plc a londonbased investment banking firm from  to  mr elser served as international vice president of northeast securities managing distressed funds for family offices and small institutions prior to that from  through  he served as a first vice president of merrill lynch capital markets in rome and london mr elser served on the board of directors of pine brook capital a shelton ctbased engineering company from  to  and was its chairman from  through  he is presently a director since  of north hills signal processing corporation a technology company and a director since  of translux corporation a designer and manufacturer of digital signage display solutions from  to  mr elser was also the president of the harvard club of italy an association he founded with other alumni in italy where he has been living since  he received his ba in economics from harvard college in  mr elser s extensive knowledge of international finance and commerce allows him to make valuable contributions as one of our directors source protalex inc on    sign up for equilar atlas and view marco m elsers full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like marco m elser more specifically youll be able to identify corporate executives in marco m elsers network and community follow changes in marco m elsers employment and moneyinmotion connect with marco m elser through your network of conections view full profile   search for over  executive profiles bio example marco m elser marco m elsers connections  sign up now to view marco m elsers  connections » jeanmarc allain president chief executive officer principal financial officer and director translux corporation kirk m warshaw former chief financial officer and secretary protalex inc jean p firstenberg former board member translux corporation arnold p kling former president protalex inc elliot sloyer former board member arotech corporation george w schiele board member translux corporation angela d toppi former executive vice president chief financial officer and assistant secretary translux corporation alan k greene former board member translux corporation kristin a kreuder former vice president general counsel and secretary translux corporation alberto shaio former board member translux corporation popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla daniel a dematteo executive chairman gamestop corp david j oconnor president and ceo the madison square garden company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   elser marco  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors elser marco check out list of companies and businesses related to elser marco find out elser marco address and contact details view other people related to elser marco  coworkers colleagues companions etc address  park avenue suite  new york  ny companies related to elser marco cikcompany namepositioncompany addresstrans lux corp park avenue suite  new york  elser marco on the web persons related to elser marco  trans lux corpnamepositioncitygreene alannew yorkshaio albertonew yorkandrew aldrichpelhamgomez alexandronew yorkjeanmarc allainpresident and ceo new yorkaldrich andrewnorwalktoppi angelanorwalkglenn angiolillonorwalksteven baruchdirector purchaserichard paul brandtdirector santa ferichard paul brandtsanta ferichard paul brandtdirector tesuquehoward brennerdirector new yorkrobert j conologuebaltimore mdrobert j conologuedarientodd dupeenorwalkmarco m elserdirector syossetmarco m elserromemarco m elserdirector romejean firstenbergdirector los angelesgabelli asset management inc et alryegabelli group capital partners incgreenwichmario j gabelliryeschiele georgenorwalkschiele georgenew yorkangiolillo glennnorwalkalan k greenedarienalan k greenedirector modlin howardnorwalkgene jankowskidirector fairfieldgene jankowskidirector alexandriafirstenberg jeannorwalkallain jeanmarcnorwalkjm allain jeanmarcnew yorkknapp jeffreynorwalkjeffrey knappannandalekristin ann kreuderstamfordkonstantinos ktistakisnew port richeyvictor s lissnorwalkvictor s lissindianapolisvictor s lissnorwalkvictor s lissdirector norwalkvictor s lissdirector stratfordjohn a longsenior vice president west des moineselser marconew yorkmulcahy michaelnorwalkhoward s modlindirector new yorkryan j morrisithacarichard mark nummiland olakesdavid joseph oshernew yorkdavid pavlikpresident of tl energy chicagoconologue robertnew yorkzizza salvatorenew yorkzizza salvatorenorwalkgeorge w schieledirector greenwichalberto shaiogreenwichalberto shaiodirector yaozhong shidirector new yorkelliot sloyerstamforddupee toddnew yorkangela toppiexecutive vice president ridgefieldshi yaozhongnew yorksalvatore j zizzadirector new yorksalvatore j zizzanorwalk other people with surname elserelser josh marco m elser  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors marco m elser check out list of companies and businesses related to marco m elser find out marco m elser address and contact details view other people related to marco m elser  coworkers colleagues companions etc address co protalex inc  columbia turnpike avenue suite  florham park  nj companies related to marco m elser cikcompany namepositioncompany addressprotalex incdirector  columbia turnpike suite  florham park  marco m elser on the web persons related to marco m elser  protalex incnamepositioncityhector w alilasenior vp of drug development new hopekling arnoldnew yorkkling arnoldflorham parkeugene a bauerdirector san rafaeleugene a bauerdirector san rafaeljohn e dohertypresident albuquerquejohn e dohertydirector new hopejohn e dohertydirector summitfrank m doughertydirector albuquerquefrank m doughertydirector new hopefrank m doughertydirector new hopefrank m doughertydirector new hopemarco m elserdirector florham parkmarco m elserdirector florham parkcarleton a holstromoaklandcarleton a holstromdirector oaklandcarleton a holstromdirector oaklandcarleton a holstromdirector new hopecarleton a holstromdirector new hopesteven h kanepresident  ceo albuquerquesteven h kanepresident and ceo new hopesteven h kanepresident new hopesteven h kanepresident new hopewarshaw kirknew hopewarshaw kirkflorham parkarnold p klingpresident new yorkarnold p klingpresident new yorkniobe ventures llcnew yorkdinesh c patelsalt lake citydinesh c pateldirector salt lake citydinesh c pateldirector salt lake cityg kirk raabdirector albuquerqueg kirk raabdirector new hopeg kirk raabdirector new hopemarc l rosenew hopemarc l rosesee remarks new hopemarc l rosevp of financecfotreasurercs new hopemarc l rosevp of fin cfo see remarks new hopevictor s sloansvp  chief medical officer new hopevictor s sloansvp  chief medical officer new hopethomas peter stagnarodirector albuquerquethomas peter stagnarodirector new hopethomas peter stagnarodirector new hopethomas peter stagnarodirector new hopethomas peter stagnarodirector new hopepeter g tombrosdirector new hopepeter g tombrosdirector new hopepeter g tombrosnew hopepeter g tombrosdirector new hopevspring sbic lpsalt lake cityvspring sbic lp owner vspring sbic lp owner salt lake citykirk m warshawchief financial officer chathamkirk m warshawnew hopekirk m warshawchief financial officer summitkirk m warshawchief financial officer florham park onemedforum ny  » emerging company finance conference » marco elser  home who we are onemedplace about contact agenda presenting companies panels workshops onemedtv webcast schedule attend attend onemedplace connect present companies apply to present meeting system onemedtv production services sponsors advisors advisors team partnering onemedplace connect   marco elser ceo  partner of capital markets advicorp rome italy marco elser was born in rome of an american father and italian mother then moved to new york city only to return to rome about  years ago he received a degree in economics from harvard in  his professional experience includes being head of international market sales for kinetix measurements in new york first vice president for merrill lynch capital markets in rome and london and head of international market and credit institutions sales for northeast securities in new york marco joined advicorp in  where he set up its capital markets operations marco has been involved in the financial services field for over  years he was a past board member of national icee corporation porta systems inc and currently chairman of universal voltronics a member of the board of north hills signal and other private companies he is specialised in restructurings and private placements he and his firm have worked on a variety of transactions in healthcare life sciences and medical technology including bracco farmaceutici coventry diagnostics orthovita photomedex cooper sciences and valeant marco is the president of the harvard club of italy he speaks english italian french and spanish fluently he is an active sportsman and is still competes in soccer skiing and polo conference info  date june   location the metropolitan club new york city audience institutional investors high net worth individual investors family offices business development executives throughout the us and europe building and financing high growth medical technology health care and life science companies view the schedule view the agenda latest tweets    years ago join the conversation contact us   e rd st new york ny  facebook twitter linked in email about onemedplace  through our news services radio interviews video production and research onemedplace specializes in delivering information to investors covering nanocap microcap and private emerging growth companies in the hottest areas of life sciences onemedplace produces a weekly newsletter and research reports covering what we believed to be an undervalued sector and has built a network of investors at all levels of financial and strategic development visit wwwonemedplacecom to learn more about the materials we provide to help give you a competitive advantage onemedforum ny  copyright   cosmo themes all rights reserved hometh annual onemedforum presenting companiesaboutaccessing european investment capital for healthcare and lifescience companies panelists adaptive designs in the medical device settingsmoreadvisorsagendabuilding a crowdfunding strategybuilding a healthcare business in europe panelistschecklist for presenting companies china forum iichina forum iiicompensation practices at life sciences companies contact usdavid chendavid strupp jrdownloadable conference bookedward borellieffective use of social media for health care related companiesentering china workshopentering europefinancing strategies for today’s turbulent and risk adverse markets funding strategies for life science companiesgoing public managing your time money and expectationskey steps to successful new product developmentma negotiationmedia servicesnathan tinkeronemedforum onemedforumsf  presenting companiesonemedplace connectonemedplace meeting systemonemedtvonemedtvonemedtv production services onemedtv webcast schedulepeoplepreparing for a reg a offeringpresentation guidelines press releases reaching family officesrecommend a panelistregisterregistrationregistrationregistrationregulatory and reimbursement panelistsreimbursement workshopresearch coverage services reverse merger workshopsales and distribution sales and distribution panelistssf presenting companiesshopping cartshopping cartsocial media to build a followingsponsorssponsorssponsorssponsorshipstan yakatanthe future of us capital marketsthe preide processa journey not a destinationthomas loarietony zhangtransatlantic conference programming using the internet to complete a reg d offeringwebcastworkshop scheduleworkshop fundraising in the life science arenaworkshop going public after the jobs actworkshop overcoming the challenges of commercializing in europeworkshop reimbursement and payer engagement strategies for market access  financing successworkshops login username password login form protected by login lockdown remember me lost your password reset password username or email log in